ANTIBIOTIC USE FOR STAPHYLOCOCCUS AUREUS PNEUMONIA IN CHILDREN
##plugins.themes.vojs.article.main##
Abstract
Staphylococcus aureus (S.aureus) is a gram-positive bacterium that causes common pyogenic infections and plays an important role in community- and hospital-acquired infections. S.aureus pneumonia can occur secondary to an infection elsewhere or primarily in the respiratory tract. The widespread and unreasonable use of antibiotics has led to the increasing antibiotic resistance of staphylococcus. Therefore, to effectively treat staphylococcal pneumonia while avoiding the risk of drug-resistant staphylococcus bacteria, it is necessary to have a reasonable antibiotic use strategy.
##plugins.themes.vojs.article.details##
Keywords
kháng sinh, Staphylococcus aureus, antibiotic
References
2. Ray MD, Boundy S, Archer GL. Transfer of the methicillin resistance genomic island among staphylococci by conjugation. Molecular microbiology 2016;100(4):675-685. https://doi.org/10.1111/mmi.13340
3. American Academy of Pediatrics. Staphylococcus aureus. Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfeld R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021:678.
4. McNeil JC, Kaplan SL. Vancomycin Therapeutic Drug Monitoring in Children: New Recommendations, Similar Challenges. J Pediatr Pharmacol Ther 2020;25(6):472-475. https://doi.org/10.5863/1551-6776-25.6.472
5. Bamberger DM, Boyd SE. Management of Staphylococcus aureus Infections. Am Fam Physician 2005;72(12):2474-2481.
6. Wunderink RG, Niederman MS, Kollef MH et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012;54(5):621-629. https://doi.org/10.1093/cid/cir895
7. Corey GR, Rubinstein E, Stryjewski ME et al. Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus. Clinical Infectious Diseases 2015;60(5):787-796. https://doi.org/10.1093/cid/ciu971
8. Esposito S, Blasi F, Curtis N et al. New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA). Antibiotics (Basel) 2023;12(4):742. https://doi.org/10.3390/antibiotics12040742
9. Frank AL, Marcinak JF, Mangat PD et al. Clindamycin treatment of methicillinresistant Staphylococcus aureus infections in children. The Pediatric Infectious Disease Journal 2022;21(6):530-534. https://doi.org/10.1097/00006454-200206000-00010
10. Stein GE, Babinchak T. Tigecycline: an update. Diagn Microbiol Infect Dis 2013;75(4):331-336. https://doi.org/10.1016/j.diagmicrobio.2012.12.004
11. Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011 52(3),285-292. https://doi.org/10.1093/cid/cir034
12. Sheldon L Kaplan. Staphylococcus aureus in children: Overview of treatment of invasive infections. Uptodate; update Jan 10, 2024.